Crohn's Disease and Colitis Trial, Recruiting NCT06632691 Sponsor: Centre Hospitalier Departemental Vendee Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT06632691
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older and have ulcerative colitis (UC), whether it is currently active or in remission
  • You have already had a rectosigmoidoscopy (a camera examination of the lower bowel) before without being put under general anaesthetic
  • You are already scheduled to have a rectosigmoidoscopy as part of your normal medical care
  • You are able to follow the study's instructions and are willing to sign a consent form agreeing to take part
  • You are covered by the French social security system or are a dependant of someone who is

Who may not be able to join:

  • You have Crohn's disease or a type of colitis that has not been clearly diagnosed
  • You are currently in hospital with a severe flare-up of colitis
  • You have a stoma (a surgical opening on your abdomen) or have previously had part of your bowel surgically removed
  • You have a diagnosed psychiatric or psychotic condition that may prevent safe use of a virtual reality headset
  • You have epilepsy that is not well controlled
  • You have significant vision problems (such as blindness or inability to use both eyes together) or significant hearing problems (such as deafness) that would prevent you from using virtual reality
  • You are currently taking part in another clinical trial that could affect this study's results
  • You have already been enrolled in this particular trial before
  • You are pregnant, recently given birth, or currently breastfeeding
  • You are under legal guardianship or have had your personal freedoms restricted by a court
  • You are under any other form of legal protection or court-ordered supervision (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Morgane AMIL, Centre Hospitalier Départemental Vendée

Phone: 0251446572

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Departemental Vendee
Registry
ClinicalTrials.gov
Start date
9 October 2024
Est. completion
9 April 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Pain intensity measured on a visual analogue scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov